Clinical trials in Bucharest – page 9

Clinical trial activity in Bucuresti includes a strong focus on cardiovascular diseases, with studies targeting atherosclerotic risk and event prevention in high-risk patients.

• Atherosclerotic cardiovascular disease
• Primary prevention of ASCVD
• Risk reduction for major cardiovascular events

These trials are mainly designed to evaluate new approaches that may lower the chance of heart attacks, strokes, and other serious vascular complications.

The nervous system diseases portfolio covers conditions affecting cognition, movement, and headache disorders, reflecting a broad interest in neurological care and symptom control.

• Agitation associated with Alzheimer’s disease
• Migraine
• Episodic migraine

Research here is focused on testing treatments that may improve daily functioning, reduce symptoms, and support long-term management in both adults and pediatric patients.

Trials in mental disorders are examining new options for people living with schizophrenia, especially those who do not respond well to standard antipsychotic treatment.

• Schizophrenia
• Adjunctive symptom management
• Treatment response in difficult-to-manage psychiatric illness

The overall aim is to better control symptoms and improve treatment effectiveness for patients with ongoing psychiatric needs.

In the area of respiratory tract diseases, studies are centered on moderate-to-severe uncontrolled asthma, with attention on therapies that may offer better symptom control.

• Moderate-to-severe uncontrolled asthma
• Symptom relief and disease control
• Safety and effectiveness of new asthma treatments

These trials are exploring whether investigational therapies can help patients breathe more easily and reduce the burden of persistent asthma.

Research in nutritional and metabolic diseases includes studies on obesity and overweight, as well as related joint problems that often accompany excess body weight.

• Obesity
• Overweight
• Knee osteoarthritis

The goal is to assess therapies that may support weight management and improve associated health outcomes, including joint pain and mobility.

Oncology research in Bucuresti includes trials for limited-stage small cell lung cancer after chemoradiotherapy, with a focus on consolidation treatment strategies.

• Limited-stage small cell lung cancer
• Post-chemoradiotherapy disease control
• Treatment effectiveness in lung cancer

These studies are evaluating whether new immunotherapy combinations can help maintain remission and improve survival outcomes.

Some trials bring together neurology and psychiatry by studying agitation in Alzheimer’s disease, an important symptom that can affect patients and caregivers alike.

• Agitation associated with Alzheimer’s disease
• Behavioral symptom management
• Long-term safety and tolerability

The research is intended to find better ways to manage distressing behavioral symptoms while supporting longer-term treatment use.

Another active area involves patients with ESKD undergoing dialysis, where studies are exploring inflammatory markers linked to cardiovascular risk.

• End-stage kidney disease
• Dialysis-associated inflammation
• Reduction of high-sensitivity C-reactive protein

These trials aim to better understand whether new therapies can help reduce inflammation and potentially improve overall health outcomes in this high-risk group.